Encouraging results. Results of a safety study on Moderna's coronavirus vaccine candidate showed that it produces virus-neutralizing antibodies in older people at levels similar to those seen in young adults.

It's endless. In the Airbus case, the WTO authorizes the EU to add tariffs on $4 billion of American products in retaliation for the subsidies received by The Boeing Company. In this 16-year-old case, everyone is right and everyone is wrong, everyone is helped but nobody wants to admit it. In the meantime, other sectors and other companies are suffering.

The disenchanted world. Walt Disney is going to lay off about 28,000 employees of its division in charge of amusement parks in the United States, because of coronavirus. About two-thirds of the jobs affected are part-time. Some of the group's parks have opened with special distancing rules, but not all, like the one in Anaheim, California, which is still closed.

Negotiations in progress. According to the Wall Street Journal, Nextera Energy has approached Duke Energy with a view to a merger, without success at the moment but with the intention of continuing discussions. A merger between the two energy companies would create a group worth about $60 billion.

It's getting clearer. The U.S. Department of Justice is expected to start proceedings against Google (Alphabet) next week on charges of anti-competitive practices, Reuters has learned. The complaint is expected to accuse Google of seeking to disadvantage its rivals, such as Microsoft's Bing search engine, by depriving them of data on users and their preferences, according to the news agency.

Caught. JPMorgan Chase will pay $920 million to shut down a case of price manipulation in the metals and treasury bill markets. This is the highest fine ever imposed in the United States for such a practice.

Detonating cocktail. Regeneron announces encouraging data for one of its treatments for mild forms of coronavirus. The cocktail of two antibodies has shown convincing results. The laboratory hopes that the US drug agency will be sensitive to these data, enough for emergency approval.

In other news. Amazon.com introduces contactless payment with the palm of your hand. Trevor Milton, Nikola's ex-boss, is accused of sexual assault by two women. Palantir's reference price set at $7.25 for the NYSE IPO. Boeing will consolidate production of its B787s in South Carolina. FDA approves Medacta's "3DMetal Femoral Cones" knee implant. The Swedish PolyPeptide Group wants to go public in Zurich. Givaudan sells its pectin business (CHF 23.2 million annual revenues) to Herbstreith & Fox of Germany. At its Investor Day, Sika confirms its 2023 targets. Caesars Entertainment will acquire William Hill at 272 GBp per share in cash. Royal Dutch Shell will cut between 7,000 and 9,000 jobs.